糖尿病
氧化应激
胰岛素
β细胞
炎症
活性氧
细胞生物学
内分泌学
医学
胰岛素敏感性
内科学
分泌物
下调和上调
细胞生长
生物
调节器
胰岛素抵抗
细胞
癌症研究
小岛
生物化学
基因
作者
Sharon Baumel-Alterzon,Liora S. Katz,Gabriel Brill,Adolfo García‐Ocaña,Donald K. Scott
标识
DOI:10.1016/j.tem.2020.11.002
摘要
Prolonged hyperglycemia is toxic to pancreatic β cells, generating excessive reactive oxygen species, defective glucose-stimulated insulin secretion, decreased insulin production, and eventually β cell death and diabetes. Nrf2 is a master regulator of cellular responses to counteract dangerous levels of oxidative stress. Maintenance of β cell mass depends on Nrf2 to promote the survival, function, and proliferation of β cells. Indeed, Nrf2 activation decreases inflammation, increases insulin sensitivity, reduces body weight, and preserves β cell mass. Therefore, numerous pharmacological activators of Nrf2 are being tested in clinical trials for the treatment of diabetes and diabetic complications. Modulating Nrf2 activity in β cells is a promising therapeutic approach for the treatment of diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI